| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |